Serum 25 hydroxycholecalciferol levels throughout pregnancy - A cross-sectional study in South Indian Pregnant Women
Article Sidebar
-
25 hydroxycholicalciferol, Pregnancy, Vitamin D, Retarded Growth
Abstract
Vitamin D deficiency has been reported worldwide. It has been reported at suboptimal levels in gestation. The levels vary during various trimesters of pregnancy. This article focuses on the gestation week wise variations observed in the serum cholecalciferol levels during gestation. 100 venous blood samples were collected from singleton, non-smoking pregnancies. The samples were collected in the summer and winter seasons during various weeks of pregnancy. The samples were collected randomly in patients who were not supplemented with vitamin D. The serum cholecalciferol levels were observed to be deficient during the first trimester (below<30 ng/ml), there was an increase in the vitamin D levels in the second trimester (levels<30 ng/ml). During the third trimester, the levels increased gradually. The ratio of cases deficient during the first trimester was higher when compared to the second and third trimesters. The serum cholecalciferol levels remain deficient due to the foetal organogenesis in the first trimester. The serum 25 hydroxy cholecalciferol levels are compensated with the development of the placenta. During the second trimester, it gradually increases and reaches sufficient limits during the third trimester.
Full text article
References
Abrams, S. A. 2007. In utero physiology: role in nutrient delivery and fetal development for calcium, phosphorus, and vitamin D. Am J Clin Nutr, 85(2):604–607.
Agudelo-Zapata, Y., Maldonado-Acosta, L. M., et al. 2018. Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women. Endocr Connect, 7(5):698–707.
Bikle, D. D., Gee, E., Halloran, B., Haddad, J. G. 1984. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest, 74(6):1966–1971.
Cross, N. A., Hillman, L. S., Allen, S. H., Krause, G. F., Vieira, N. E. 1995. Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr, 61(3):514–523.
Hollis, B. W., Roos, B. A., Draper, H. H., Lambert, P. W. 1981. Vitamin D and its metabolites in human and bovine milk. J Nutr, 111(7):1240–1248.
Hong, J. S., Santolaya-Forgas, J., Romero, R. 2005. Maternal plasma osteoprotegerin concentration in normal pregnancy. Am J Obstet Gynecol, 193(3 pt 2):1011–1015.
Khemka, A., Naveen, A. S., Singh, K., Bansal, S. K. 2020. Role of Vitamin D Supplementation in Prevention and Treatment of COVID-19. Indian J Clin Biochem, 35(4):502–503.
Mulligan, M. L., Felton, S. K., Riek, A. E., Bernal-Mizrachi, C. 2010. Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol, 202(5):429–430.
Ritchie, L. D., Fung, E. B., Halloran, B. P. 1998. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after the resumption of menses. Am J Clin Nutr, 67(4):693–701.
Taylor, T. G., Lewis, P. E., Balderstone, O. 1975. Role of calcitonin in protecting the skeleton during pregnancy and lactation. J Endocrinol, 66(2):297–305.
Uemura, H., Yasui, T., Kiyokawa, M. 2002. Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol, 174(2):353–359.
Wilson, S. G., Retallack, R. W., Kent, J. C., Worth, G. K., Gutteridge, D. H. 1990. Serum-free 1,25-dihydroxy vitamin D and the free 1,25-dihydroxy vitamin D index during a longitudinal study of human pregnancy and lactation. Clin Endocrinol (Oxf), 32(5):613–622.
Zhang, Y. G., Wu, S., Sun, J. 2013. Vitamin D, vitamin D receptor, and tissue barriers. Tissue Barriers, 1(1):1–7.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.